Date: November 20, 2020
PharmaCielo is a global company, headquartered in Canada. They're focusing on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo is also the first company to hold Colombian licences for cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD). This makes them the world’s largest licensed producer.
Moreover, the company's medicinal-grade oil extracts and related products provide reliable, standardized relief and wellness formulas for patients in need. This includes those requiring higher levels of THC.
The company has expanded its processing capabilities which has significantly helped scale up production as well as ramp up global market revenues.
PharmaCielo’s principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing centre located in Rionegro, Colombia.
The board of directors and executive team are comprised of a diversely talented group of international business executives. It also holds specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia’s ideal location plays in building a sustainable business in the medical cannabis industry. The company, together with its directors and executives, is executing on a business plan focused on supplying the international marketplace.
For more information on PharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) please fill out the form below.